Frequent microsatellite instability in primary small cell lung cancer.

Adrian Merlo, M Mabry, Edward Gabrielson, +3

PubMed

Tumor BiologyFrequent Microsatellite InstabilityOncologyCancer PathologyMicrosatellite Sequences +12

Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer

Margaret A. Tucker, Nevin Murray, Edward G. Shaw, +9

JNCI Journal of the National Cancer Institute

Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: Relationship to the response of lung tumor xenografts to mitomycin C

Alvin M. Malkinson, David Siegel, Gerald L. Forrest, +7

Lung Cancer

Oncogenic AgentMedicineDt-diaphorase ActivityPathologyMessenger Rna Content +8

Activated Raf-1 causes growth arrest in human small cell lung cancer cells.

Rajani Ravi, Erich Weber, Martin McMahon, +9

Journal of Clinical Investigation

Estrogen ReceptorCancer BiologyRaf-1 Causes GrowthTumor BiologyLung Cancers +15

Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody.

Rolf A. Stahel, M Mabry, Arthur T. Skarin, +2

Journal of Clinical Oncology

Murine Monoclonal AntibodyCancer ImmunosurveillanceOncologic ImagingCancer DetectionBone Marrow Metastasis +11

Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.

Takeshi Nakagawa, M Mabry, A de Bustros, +3

Proceedings of the National Academy of Sciences

Oncogenic AgentMedicineThyroid DiseaseGene ExpressionImmunology +12

Growth Inhibition and Induction of Apoptosis by Fenretinide in Small-Cell Lung Cancer Cell Lines

Gregory P. Kalemkerian, Rodney Slusher, Sakkaraiappan Ramalingam, +2

JNCI Journal of the National Cancer Institute

Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer

Adrian Merlo, Edward Gabrielson, M Mabry, +3

Lung Cancer

Homozygous DeletionChromosome 9PTumor HeterogeneityGeneticsPathology +6

v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer.

M Mabry, Takeshi Nakagawa, Barry D. Nelkin, +5

Proceedings of the National Academy of Sciences

OncologyTumor MicroenvironmentSclc Cell LinesMedicineOncogenic Agent +13

v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line.

Joseph Falco, S B Baylin, Ruth Lupu, +5

Journal of Clinical Investigation

Tumor BiologyNsclc PhenotypeSclc Cell LinesMedicineOncogenic Agent +12